• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Helix BioPharma Corp

+ Add to Watchlist


1.286 EUR 0.083 6.90%

As of 02:16:04 ET on 08/20/2014.

Snapshot for Helix BioPharma Corp (HBP)

Open: 1.120 Day's Range: 1.120 - 1.334 Volume: 0
Previous Close: 1.203 52wk Range: 0.695 - 1.540 1-Yr Rtn: +68.55%

Stock Chart for HBP

No chart data available.
  • HBP:GR 1.286
  • 1D
  • 1M
  • 1Y
Interactive HBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBP

Current P/E Ratio (ttm) -
Estimated P/E(07/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (07/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 97.61
Shares Outstanding (M) 75.90
30 Day Average Volume 502
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBP

No data available

Company Profile & Key Executives for HBP

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its proprietary technologies.

Robert A VerhagenPresident/CEOPhotios Michalargias "Frank"Chief Financial Officer
Heman ChaoChief Scientific Officer
More Company Profile & Key Executives for HBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil